
Nicolas Barros
@nicobarrosid
Transplant Infectious Diseases at IU Health (@IU_Health)
Assistant Professor at IUPUI (@IUIDfellowship)
ID: 1363672754101321729
22-02-2021 02:11:47
144 Tweet
566 Followers
186 Following

Hey, new #IDfellows TxID Early Career Network! Did you know we often check levels of antifungal drugs? These infographics have it all in one place! Added to transplantid.net: "DRUGS AND THERAPIES"▶️"Antifungals"📁 "CORE CURRICULUM"▶️"ORGANISM"▶️"FUNGI"📁 transplantid.net/94T8PTJX


Now in Open Forum Infectious Diseases - Therapeutic Myths in TID! 1⃣ ASx bacteriuria 🚫 Rx 2⃣ SOT 🙅 routine dental ppx 3⃣ VGCV conc. have unclear utility 🤷 4⃣ IVIG 🚫 BK 5⃣ Evaluate TMP-SMX allergy 💊 6⃣ Vaccines ✅ Added to Drugs & Therapies 📁 by Dilek Ince Carver College of Medicine transplantid.net/5ZA8BHSF


It's a MUST read article. Thanks Camille Camille Nelson Kotton and team. transplantid.net Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 academic.oup.com/cid/article/do…

Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa. Histoplasma antigenuria in 11% of PLWHIV and 13% of 483 persons with advanced HIV disease. Thanks to @NateBahrID Dr. David B and collaborators! wwwnc.cdc.gov/eid/article/30…

🚨NEWS FLASH!🚨 Due to popular demand, transplantid.net now has a new JOURNAL CLUB section This month Nicolas Barros & Pascalis Vergidis MD, MSc discuss 200-day letermovir prophylaxis in HSCT! The Lancet Haematology ASTCT The EBMT Their excellent discussion at transplantid.net/MY26WACL


What, you didn't think that transplantid.net already had a folder for this great review from Olivia Kates, MD and colleagues in TransplantID Journal? ORGANISMS▶️VIRUSES▶️HHV-8📂 transplantid.net/4U5ATKXK


The conclusion of this American Journal of Transplantation study: "the use of contemporary doses of lymphodepleting agents, whether ATG or alemtuzumab, for induction in EBV R-/D+ is associated with a higher risk of PTLD compared with basiliximab" transplantid.net/26H7QFNE


Excited to share the August 2024 journal club from Nicolas Barros and Pascalis Vergidis MD, MSc! "#Belatacept and Infection - Think Fungus!" Click here➡️transplantid.net/BRKMCYU7⬅️ Also, a letter discussing definitions of invasive fungal disease used in the study doi.org/10.1093/ofid/o…

Please join me in congratulating Dr. William (Bill) Goggins, who just performed his career 3000th kidney transplant!!! An unparalleled accomplishment for a single surgeon! Indiana Surgery -Indiana Univ School of Medicine


🚨 CRITICAL READ 🚨 If you do research in Transplant ID, this paper is a MUST read. From @CMDurandMD and the The Transplant Research Center a brilliant blueprint in how to build a successful transplant research center. From TransplantID Journal onlinelibrary.wiley.com/doi/10.1111/ti…

Great review article on "Diagnosis and prevention of invasive fungal infections in the immunocompromised host" by one of the transplantid.net members Pascalis Vergidis MD, MSc! 10.1016/j.chest.2024.08.046


⚠️Happy to share our first Journal Club in collaboration with transplantid.net Nicolas Barros and Pascalis Vergidis MD, MSc How often do SOTRs taking Belatacept develop IFI? ➡️ 15.3% developed IFI ➡️Aspergillus (56%) followed by Candidiasis (22%) ➡️ Higher incidence in LTx


#HepatitisB after #ibrutinib in Open Forum Infectious Diseases - VA database 2014-19 - 7 reactivations/181 HepB coreAb+ - excluded other drugs such as rituximab Rate of 3.9% in line with other studies ⁉️Should we give HBV ppx for ibrutinib like we do for rituximab⁉️ transplantid.net/JBAECYS6